Back to Results

Doximity Inc (DOCS)

Featured in High-Beta Stocks

Doximity, Inc. is a healthcare technology company that operates a digital platform for medical professionals in the United States. Its software tools are designed to support clinical collaboration, access to medical news and research, career management, on-call scheduling, documentation workflows, and virtual patient visits. The platform serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. Founded in 2010 and headquartered in San Francisco, California, the company was previously known as 3MD Communications, Inc. before adopting the Doximity name in June 2010. The listed security is common stock on the New York Stock Exchange under the symbol DOCS.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-DOCS
$31.97
50.6% Upside
Bargain
$24.56
15.7% Upside
Fair
Great
—
—
—
0.0%
August 6, 2026
19.6x
4.0x
5.9x
3.906 B
3.096 B
0.3%
69.9%
15.8
—
166.5%
Send a message
Valuation • Fair Value

Doximity Inc (NYSE-DOCS) Fair Value by Valuation Model

Compare the primary fair value estimate for Doximity Inc (NYSE-DOCS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$31.97

Estimated upside of 50.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$34.13

Discounted cash flow valuation reference.

Ben Graham Formula Value

$12.10

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$17.14

Earnings power value estimate.

Comps Fair Value

$32.28

Comparable-company valuation reference.

Analyst Price Target

$24.56

Analysts imply upside of 15.7%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Doximity Inc (NYSE-DOCS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Doximity Inc (NYSE-DOCS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

644.9 M

Current operating scale indicator.

Revenue Forecast

670.5 M

Forward revenue estimate.

EBITDA

228.8 M

Current operating profitability reference.

EBITDA Forecast

329 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Doximity Inc (NYSE-DOCS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Doximity Inc (NYSE-DOCS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.92

No elevated caution signal from this screen.

Altman Z-Score

15.8

Relatively strong balance-sheet zone.

FCF / Net Income

166.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Doximity Inc (NYSE-DOCS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Doximity Inc (NYSE-DOCS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Doximity Inc (NYSE-DOCS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Doximity Inc (NYSE-DOCS) Stock Forecast & Technical Outlook

Review Doximity Inc (NYSE-DOCS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Doximity Inc (NYSE-DOCS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Doximity Inc (NYSE-DOCS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Doximity Inc (NYSE-DOCS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Doximity Inc (NYSE-DOCS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Doximity Inc (NYSE-DOCS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Doximity Inc (NYSE-DOCS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Doximity Inc (NYSE-DOCS) has a Hold consensus, with 4 buy, 11 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 11
Sell 0
FAQ • Fast Investor Answers

Doximity Inc (NYSE-DOCS) Stock FAQ

Quick answers about Doximity Inc (NYSE-DOCS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$31.97
Estimated upside 50.6%
Valuation Rating
Undervalued
Estimated upside of 50.6%
Analyst Target
$24.56
Implied upside 15.7%
Financial Health
Great
Current financial-health read

The current fair value estimate for Doximity Inc (NYSE-DOCS) is $31.97. This implies an estimated upside of 50.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 50.6% versus the current market price.

The available analyst price target for Doximity Inc (NYSE-DOCS) is $24.56. The analyst target implies estimated upside of 15.7%.

The current financial health read for Doximity Inc (NYSE-DOCS) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Doximity Inc (NYSE-DOCS) is August 6, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Doximity Inc (NYSE-DOCS) is 19.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Doximity Inc is 3.906 B.

The current enterprise value listed for Doximity Inc is 3.096 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Doximity Inc is NYSE-DOCS, and the stock is listed on NYSE.

Doximity Inc (NYSE-DOCS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Doximity Inc is 0.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Doximity Inc is 69.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NYSE View more

Veeva Systems Inc Class A (VEEV) Veeva Systems Inc Class A (VEEV)
Teladoc Inc (TDOC) Teladoc Inc (TDOC)
Evolent Health Inc (EVH) Evolent Health Inc (EVH)
Phreesia Inc (PHR) Phreesia Inc (PHR)
Claritev Corp (CTEV) Claritev Corp (CTEV)
American Well Corp (AMWL) American Well Corp (AMWL)